Neuralgic amyotrophy and infectious mononucleosis: a case report

T Esmonde1, W Gamble, V Patterson

  • 1Royal Victoria Hospital, Belfast, Greenisland, UKGreenisland Health Centre, Greenisland, UK.

Insights

A young man experienced neuralgic amyotrophy, a nerve condition, affecting his right arm after an Epstein-Barr virus infection. This nerve disorder occurred in an arm previously used for strenuous manual labor.

Area of Science:

  • Neurology
  • Virology
  • Immunology

Background:

  • Neuralgic amyotrophy, also known as Parsonage-Turner syndrome, is an idiopathic neuropathy characterized by sudden onset of severe pain followed by muscle weakness and atrophy.
  • Epstein-Barr virus (EBV) is a common human herpesvirus that can cause a range of illnesses, including infectious mononucleosis.
  • While EBV is a known trigger for various neurological complications, its direct association with neuralgic amyotrophy is less commonly reported.

Purpose of the Study:

  • To report a case of neuralgic amyotrophy following an Epstein-Barr virus infection.
  • To investigate the potential link between EBV and the development of neuralgic amyotrophy.
  • To highlight the clinical presentation and potential contributing factors in this case.

Main Methods:

  • Case report of a 27-year-old male patient.
  • Serological testing to confirm Epstein-Barr virus infection.
  • Clinical assessment of neurological symptoms and limb function.

Main Results:

  • The patient developed neuralgic amyotrophy of the right upper limb five weeks after an acute febrile illness.
  • Epstein-Barr virus infection was confirmed serologically as the cause of the febrile illness.
  • The affected limb had been subjected to heavy manual labor prior to the onset of weakness.

Conclusions:

  • Epstein-Barr virus infection can be a potential trigger for neuralgic amyotrophy.
  • Heavy manual labor may be a contributing factor in the development of neuralgic amyotrophy in susceptible individuals.
  • This case adds to the understanding of EBV-associated neurological complications and parallels with other post-infectious neuropathies.

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
27
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
69
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
30
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
187
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K